Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
AstraZeneca
Moodys
Cerilliant
Harvard Business School
Colorcon
Dow
Medtronic
Boehringer Ingelheim
Argus Health

Generated: August 17, 2017

DrugPatentWatch Database Preview

PROBENECID AND COLCHICINE Drug Profile

« Back to Dashboard

Which patents cover Probenecid And Colchicine, and when can generic versions of Probenecid And Colchicine launch?

Probenecid And Colchicine is a drug marketed by Ingenus Pharms Nj, Impax Labs, Beecham, Sandoz, and Ani Pharms Inc. and is included in five NDAs.

The generic ingredient in PROBENECID AND COLCHICINE is colchicine; probenecid. There are fifteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.

Summary for Tradename: PROBENECID AND COLCHICINE

Patents:0
Applicants:5
NDAs:5
Suppliers / Packagers: see list2
Clinical Trials: see list105,561
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROBENECID AND COLCHICINE at DailyMed

Pharmacology for Tradename: PROBENECID AND COLCHICINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ingenus Pharms Nj
PROBENECID AND COLCHICINE
colchicine; probenecid
TABLET;ORAL040618-001May 13, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
PROBENECID AND COLCHICINE
colchicine; probenecid
TABLET;ORAL086130-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Impax Labs
PROBENECID AND COLCHICINE
colchicine; probenecid
TABLET;ORAL083720-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Beecham
PROBENECID AND COLCHICINE
colchicine; probenecid
TABLET;ORAL084321-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
PROBENECID AND COLCHICINE
colchicine; probenecid
TABLET;ORAL083734-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Johnson and Johnson
AstraZeneca
US Department of Justice
US Army
Harvard Business School
QuintilesIMS
Novartis
Merck
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot